CCL24, CXCL9, and CXCL10 are increased in synovial fluid in patients with juvenile idiopathic arthritis requiring advanced treatment.
Sign Up to like & getrecommendations! Published in 2022 at "Rheumatology"
DOI: 10.1093/rheumatology/keac617
Abstract: OBJECTIVE Oligoarticular Juvenile Idiopathic Arthritis (JIA) disease progression and outcomes are variable. Our objective is to detect protein markers that would allow for earlier intervention to potentially halt disease progression. In this retrospective study of… read more here.
Keywords: advanced treatment; cxcl9 cxcl10; ccl24 cxcl9; synovial fluid ... See more keywords
Plasma CXCL9 and CXCL10 at allograft injury predict chronic lung allograft dysfunction
Sign Up to like & getrecommendations! Published in 2022 at "American Journal of Transplantation"
DOI: 10.1111/ajt.17108
Abstract: Histopathologic lung allograft injuries are putative harbingers for chronic lung allograft dysfunction (CLAD). However, the mechanisms responsible are not well understood. CXCL9 and CXCL10 are potent chemoattractants of mononuclear cells and potential propagators of allograft… read more here.
Keywords: plasma cxcl9; injury; cxcl9 cxcl10; allograft ... See more keywords
EBV‐positive pyothorax‐associated lymphoma expresses CXCL9 and CXCL10 chemokines that attract cytotoxic lymphocytes via CXCR3
Sign Up to like & getrecommendations! Published in 2023 at "Cancer Science"
DOI: 10.1111/cas.15782
Abstract: Epstein–Barr virus (EBV)‐positive diffuse large B‐cell lymphoma associated with chronic inflammation (DLBCL‐CI) develops in the setting of long‐standing inflammation. This type of lymphoma may have specific expression profiles of chemokines involved in the pathogenesis of… read more here.
Keywords: lymphoma; cxcl9 cxcl10; dlbcl; cxcr3 ... See more keywords
Glucocorticoids target the CXCL9/CXCL10-CXCR3 axis and confer protection against immune-mediated kidney injury
Sign Up to like & getrecommendations! Published in 2022 at "JCI Insight"
DOI: 10.1172/jci.insight.160251
Abstract: Glucocorticoids remain a cornerstone of therapeutic regimes for autoimmune and chronic inflammatory diseases — for example, in different forms of crescentic glomerulonephritis — because of their rapid antiinflammatory effects, low cost, and wide availability. Despite… read more here.
Keywords: protection immune; cxcl10 cxcr3; cxcr3 axis; cxcl9 cxcl10 ... See more keywords
CXCL9, CXCL10, and CXCL11; biomarkers of pulmonary inflammation associated with autoimmunity in patients with collagen vascular diseases–associated interstitial lung disease and interstitial pneumonia with autoimmune features
Sign Up to like & getrecommendations! Published in 2020 at "PLoS ONE"
DOI: 10.1371/journal.pone.0241719
Abstract: Introduction Interstitial lung disease (ILD) is a heterogeneous group of diseases characterized by varying degrees of lung inflammation and/or fibrosis. We investigated biomarkers to infer whether patients with collagen vascular diseases associated ILD (CVD–ILD) and… read more here.
Keywords: cxcl11; cvd ild; levels cxcl9; cxcl10 cxcl11 ... See more keywords
The Pro-Inflammatory Chemokines CXCL9, CXCL10 and CXCL11 Are Upregulated Following SARS-CoV-2 Infection in an AKT-Dependent Manner
Sign Up to like & getrecommendations! Published in 2021 at "Viruses"
DOI: 10.3390/v13061062
Abstract: Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) is a highly transmissible RNA virus that is the causative agent of the Coronavirus disease 2019 (COVID-19) pandemic. Patients with severe COVID-19 may develop acute lung injury (ALI)… read more here.
Keywords: inflammatory chemokines; sars cov; cxcl10 cxcl11; pro inflammatory ... See more keywords